SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-024876
Filing Date
2021-02-17
Accepted
2021-02-17 17:11:11
Documents
9
Period of Report
2021-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm217074d1_8k.htm 8-K 36171
2 EXHIBIT 5.1 tm217074d1_ex5-1.htm EX-5.1 9392
3 EXHIBIT 10.1 tm217074d1_ex10-1.htm EX-10.1 196601
4 EXHIBIT 99.1 tm217074d1_ex99-1.htm EX-99.1 167862
5 EXHIBIT 99.2 tm217074d1_ex99-2.htm EX-99.2 10492
6 EXHIBIT 99.3 tm217074d1_ex99-3.htm EX-99.3 10439
7 GRAPHIC tm217074d1_ex5-1img001.jpg GRAPHIC 27666
8 GRAPHIC tm217074d1_ex99-2img001.jpg GRAPHIC 4973
9 GRAPHIC tm217074d1_ex99-3img001.jpg GRAPHIC 4973
  Complete submission text file 0001104659-21-024876.txt   484529
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36333 | Film No.: 21646008
SIC: 2834 Pharmaceutical Preparations